Ameliorative Effect of Dangguibuxue Decoction against Cyclophosphamide-Induced Heart Injury in Mice

Area of Science:

• Cardiovascular Pharmacology
• Traditional Chinese Medicine
• Toxicology

Background:

• Cyclophosphamide (CTX) is a widely used chemotherapy agent with known cardiotoxic side effects.
• Myocardial injury is a significant concern in patients undergoing CTX treatment.
• Dangguibuxue decoction (DBD) is a traditional Chinese herbal formula historically used for blood deficiency.

Purpose of the Study:

• To investigate the protective effects of Dangguibuxue decoction (DBD) against cyclophosphamide (CTX)-induced myocardial injury in a mouse model.
• To elucidate the potential mechanisms underlying DBD's cardioprotective effects, focusing on the NF-κB signaling pathway.

Main Methods:

• Mice were induced with cyclophosphamide (CTX) to establish a model of myocardial injury.
• Serum levels of cardiac enzymes (ALT, AST, CK, LDH) and white blood cell counts were measured.
• Pathological changes in heart tissue were assessed.
• Protein expression levels in the NF-κB signaling pathway were analyzed.

Main Results:

• DBD treatment significantly reduced elevated serum levels of ALT, AST, CK, and LDH in CTX-induced mice.
• DBD administration ameliorated the pathological damage observed in heart tissues.
• DBD significantly decreased the protein expression of key components within the NF-κB signaling pathway.

Conclusions:

• Dangguibuxue decoction (DBD) demonstrates significant cardioprotective effects against cyclophosphamide-induced myocardial injury in mice.
• The findings suggest that DBD exerts its protective effects, at least in part, by modulating the NF-κB signaling pathway.
• DBD can be considered a potential therapeutic agent for mitigating chemotherapy-induced cardiotoxicity.